Literature DB >> 9881767

Inhibition of the type 1 fimbriae-mediated adhesion of Escherichia coli to erythrocytes by multiantennary alpha-mannosyl clusters: the effect of multivalency.

T K Lindhorst1, C Kieburg, U Krallmann-Wenzel.   

Abstract

Alpha-mannosyl glycoclusters and glycodendrimers were tested as multivalent inhibitors of the type 1 (mannose-specific) fimbriae of a recombinant E. coli HB101 strain. Inhibition of haemagglutination of guinea pig erythrocytes was determined on microtiter plates. The effect of multivalency is pronounced for up to three mannosyl residues in the molecule, whereas larger derivatives do not have an appreciable effect on binding to the fimbrial carbohydrate binding domain. The best glycoclusters tested reach the binding potency of the known potent inhibitor pNPMan (3). The results support the idea of a monovalent recognition site at the adhesive protein FimH, which might best accommodate molecules with the size of a trisaccharide or those which expose up to three alpha-mannosyl residues, such as the glycocluster 8. The results obtained with the thiourea-bridged alpha-mannosyl clusters, possessing defined sugar valencies, facilitate the development of high affinity inhibitors of the fimbrial lectin on type 1 fimbriae.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9881767     DOI: 10.1023/a:1006920027641

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  22 in total

Review 1.  Syntheses and some applications of chemically defined multivalent glycoconjugates.

Authors:  R Roy
Journal:  Curr Opin Struct Biol       Date:  1996-10       Impact factor: 6.809

2.  Interaction of mannose-containing oligosaccharides with the fimbrial lectin of Escherichia coli.

Authors:  N Firon; I Ofek; N Sharon
Journal:  Biochem Biophys Res Commun       Date:  1982-04-29       Impact factor: 3.575

Review 3.  Fimbrial adhesions of Escherichia coli.

Authors:  P Klemm
Journal:  Rev Infect Dis       Date:  1985 May-Jun

4.  Carbohydrate-binding sites of the mannose-specific fimbrial lectins of enterobacteria.

Authors:  N Firon; I Ofek; N Sharon
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

5.  The fimA gene encoding the type-1 fimbrial subunit of Escherichia coli. Nucleotide sequence and primary structure of the protein.

Authors:  P Klemm
Journal:  Eur J Biochem       Date:  1984-09-03

6.  Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated Escherichia coli to yeast and intestinal epithelial cells.

Authors:  N Firon; S Ashkenazi; D Mirelman; I Ofek; N Sharon
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

Review 7.  Bacterial lectins, cell-cell recognition and infectious disease.

Authors:  N Sharon
Journal:  FEBS Lett       Date:  1987-06-15       Impact factor: 4.124

8.  Carbohydrate specificity of the surface lectins of Escherichia coli, Klebsiella pneumoniae, and Salmonella typhimurium.

Authors:  N Firon; I Ofek; N Sharon
Journal:  Carbohydr Res       Date:  1983-08-16       Impact factor: 2.104

9.  Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract.

Authors:  I Connell; W Agace; P Klemm; M Schembri; S Mărild; C Svanborg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

Review 10.  Biological roles of oligosaccharides: all of the theories are correct.

Authors:  A Varki
Journal:  Glycobiology       Date:  1993-04       Impact factor: 4.313

View more
  16 in total

1.  Structure-based drug design and optimization of mannoside bacterial FimH antagonists.

Authors:  Zhenfu Han; Jerome S Pinkner; Bradley Ford; Robert Obermann; William Nolan; Scott A Wildman; Doug Hobbs; Tom Ellenberger; Corinne K Cusumano; Scott J Hultgren; James W Janetka
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

2.  Elevated shear stress protects Escherichia coli cells adhering to surfaces via catch bonds from detachment by soluble inhibitors.

Authors:  Lina M Nilsson; Wendy E Thomas; Evgeni V Sokurenko; Viola Vogel
Journal:  Appl Environ Microbiol       Date:  2006-04       Impact factor: 4.792

3.  Lead optimization studies on FimH antagonists: discovery of potent and orally bioavailable ortho-substituted biphenyl mannosides.

Authors:  Zhenfu Han; Jerome S Pinkner; Bradley Ford; Erik Chorell; Jan M Crowley; Corinne K Cusumano; Scott Campbell; Jeffrey P Henderson; Scott J Hultgren; James W Janetka
Journal:  J Med Chem       Date:  2012-04-13       Impact factor: 7.446

Review 4.  Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease.

Authors:  Laurel K Mydock-McGrane; Thomas J Hannan; James W Janetka
Journal:  Expert Opin Drug Discov       Date:  2017-06-02       Impact factor: 6.098

Review 5.  Design and creativity in synthesis of multivalent neoglycoconjugates.

Authors:  Yoann M Chabre; René Roy
Journal:  Adv Carbohydr Chem Biochem       Date:  2010       Impact factor: 12.200

6.  Carbohydrate phenotyping of human and animal milk glycoproteins.

Authors:  Anki Gustafsson; Imre Kacskovics; Michael E Breimer; Lennart Hammarström; Jan Holgersson
Journal:  Glycoconj J       Date:  2005-03       Impact factor: 2.916

Review 7.  Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases.

Authors:  Meredith A Mintzer; Eric L Dane; George A O'Toole; Mark W Grinstaff
Journal:  Mol Pharm       Date:  2011-12-13       Impact factor: 4.939

Review 8.  Receptor mimicry as novel therapeutic treatment for biothreat agents.

Authors:  Richard J Thomas
Journal:  Bioeng Bugs       Date:  2010 Jan-Feb

9.  En route to photoaffinity labeling of the bacterial lectin FimH.

Authors:  Thisbe K Lindhorst; Michaela Märten; Andreas Fuchs; Stefan D Knight
Journal:  Beilstein J Org Chem       Date:  2010-08-26       Impact factor: 2.883

10.  Recognition of blood group ABH type 1 determinants by the FedF adhesin of F18-fimbriated Escherichia coli.

Authors:  Annelies Coddens; Mette Diswall; Jonas Angström; Michael E Breimer; Bruno Goddeeris; Eric Cox; Susann Teneberg
Journal:  J Biol Chem       Date:  2009-02-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.